Intraoperative Mitomycin C in Lacrimal Sac Mucocele

NCT ID: NCT03176355

Last Updated: 2017-06-05

Study Results

Results pending

The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

COMPLETED

Clinical Phase

NA

Total Enrollment

30 participants

Study Classification

INTERVENTIONAL

Study Start Date

2011-03-23

Study Completion Date

2013-01-07

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

30 patients had lacrimal sac mucocele and dacryocystorhinostomy was done for them with intraoperative mitomycin C was added to decrease postoperative fibrosis and recurrence.

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

Lacrimal Mucocele

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Allocation Method

NA

Intervention Model

SINGLE_GROUP

Primary Study Purpose

TREATMENT

Blinding Strategy

NONE

Study Groups

Review each arm or cohort in the study, along with the interventions and objectives associated with them.

Chronic dacryocystitis patients

Group Type OTHER

Canaliculo- Dacryocystorhinostomy

Intervention Type PROCEDURE

Bypass lacrimal passage obstruction by opening a shunt between the lacrimal sac and the nasal mucosa

Interventions

Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.

Canaliculo- Dacryocystorhinostomy

Bypass lacrimal passage obstruction by opening a shunt between the lacrimal sac and the nasal mucosa

Intervention Type PROCEDURE

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

* Lacrimal sac mucocele

Exclusion Criteria

* Paediatric patients (less than 16 years old).
* Previous lacrimal passage procedure.
* Neoplasms as secondary causes of obstruction.
Minimum Eligible Age

20 Years

Maximum Eligible Age

70 Years

Eligible Sex

ALL

Accepts Healthy Volunteers

No

Sponsors

Meet the organizations funding or collaborating on the study and learn about their roles.

Minia University

OTHER

Sponsor Role lead

Responsible Party

Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.

Mohamed Farag Khalil Ibrahiem

Lecturer of ophthalmology

Responsibility Role PRINCIPAL_INVESTIGATOR

Other Identifiers

Review additional registry numbers or institutional identifiers associated with this trial.

Minia Hospital

Identifier Type: -

Identifier Source: org_study_id

More Related Trials

Additional clinical trials that may be relevant based on similarity analysis.

Amniotic Membrane for Dacryocystorhinostomy
NCT06226181 RECRUITING PHASE1
Two Different Surgical Methods of Blepharospasm
NCT02765113 UNKNOWN EARLY_PHASE1